S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Laser breakthrough could send stock soaring 2,467% (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Laser breakthrough could send stock soaring 2,467% (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Strange change at your bank (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Laser breakthrough could send stock soaring 2,467% (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Laser breakthrough could send stock soaring 2,467% (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Strange change at your bank (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Laser breakthrough could send stock soaring 2,467% (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Laser breakthrough could send stock soaring 2,467% (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Strange change at your bank (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Laser breakthrough could send stock soaring 2,467% (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Laser breakthrough could send stock soaring 2,467% (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Strange change at your bank (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double

Xenetic Biosciences (XBIO) Earnings Date, Estimates & Call Transcripts

$3.85
+0.01 (+0.26%)
(As of 02/20/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

XBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xenetic Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.82) EPS
Next Year EPS Consensus Estimate: ($0.64) EPS

XBIO Earnings Date and Information

Xenetic Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off prior year's report dates.

Xenetic Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/28/2024
Estimated)
------- 
11/10/2023Q3 2023($1.12)($0.69)+$0.43($0.69)$0.46 million$0.61 million
8/11/2023Q2 2023($1.13)($0.69)+$0.44($0.69)$0.44 million$0.65 million
5/11/2023Q1 2023($1.10)($0.60)+$0.50($0.60)$0.41 million$0.61 million
3/23/2023Q4 2022-($1.00)($1.00)($1.00)$0.18 million$0.49 million
11/10/2022Q3 2022($1.80)($0.60)+$1.20($0.06)$0.35 million$0.41 million
8/12/2022Q2 2022($1.20)($1.90)($0.70)($0.19)$0.34 million$0.42 million
5/12/2022Q1 2022($1.10)($1.20)($0.10)($0.12)$0.34 million$0.39 million
11/11/2021-($1.20)($1.30)($0.10)($0.13)$0.20 million$0.35 million
8/11/2021-($1.60)($1.30)+$0.30($0.13)$0.19 million$0.29 million    
5/10/2021Q1($1.30)($1.50)($0.20)($0.15)$0.10 million$0.19 million
3/16/2021Q4 2020-($1.50)($1.50)($0.15)-$0.15 million












Xenetic Biosciences Earnings - Frequently Asked Questions

When is Xenetic Biosciences's earnings date?

Xenetic Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off last year's report dates. Learn more on XBIO's earnings history.

How much revenue does Xenetic Biosciences generate each year?

Xenetic Biosciences (NASDAQ:XBIO) has a recorded annual revenue of $1.71 million.

How much profit does Xenetic Biosciences generate each year?

Xenetic Biosciences (NASDAQ:XBIO) has a recorded net income of -$6.55 million. XBIO has generated -$2.98 earnings per share over the last four quarters.

What is Xenetic Biosciences's EPS forecast for next year?

Xenetic Biosciences's earnings are expected to grow from ($2.82) per share to ($0.64) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:XBIO) was last updated on 2/21/2024 by MarketBeat.com Staff